ImmunityBio
IBRX
IBRX
47 hedge funds and large institutions have $6.47M invested in ImmunityBio in 2019 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
-11
Holders Change %
-18.97%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
20
Closed
18
Calls
$1K
Puts
$53K
Net Calls
-$52K
Net Calls Change
-$5K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$852K |
| 2 |
2
Renaissance Technologies
New York
|
$1.54M |
| 3 |
PP
3
Paloma Partners
Greenwich,
Connecticut
|
$127K |
| 4 |
4
Jane Street
New York
|
$92K |
| 5 |
5
Goldman Sachs
New York
|
$79K |
